Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109824562A reveals ultrasonic lactic acid catalysis for high-purity intermediates. Offers significant cost reduction and supply chain reliability for global buyers.
Patent CN102827030A details a safe, high-yield route for (3R,5R)-3,5-dihydroxy-6-cyanohexanoate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN107311868B details a green esterification method offering high purity and recyclable catalysts for scalable pharma intermediate manufacturing and supply chain efficiency.
Patent CN107311868B details a green resin catalyst method for methyl p-tert-butylbenzoate ensuring high purity and reduced corrosion for reliable supply chains.
Patent CN108948059B reveals solvent-free boronation using Mg catalysts. Reduces cost and toxicity for high-purity pharmaceutical intermediates manufacturing.
Novel sulfonic acid resin catalyzed esterification ensures high purity and reduced corrosion for reliable methyl p-tert-butylbenzoate supply chain optimization.
Patent CN114181080B enables green synthesis of Indoxacarb intermediate with water solvent, offering cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN112811986A reveals a dual-acid catalytic route for triaryl ethylenes. This method offers high stereoselectivity and mild conditions for pharmaceutical intermediates.
Novel silver-catalyzed route for Jaspine B isomer synthesis. Reduces cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Advanced low-temperature synthesis of PFPN flame retardant. High purity 99.9%, scalable process for lithium battery electrolyte manufacturing.
Patent CN116003429B reveals high-yield 6FCDA synthesis. Offers supply chain reliability and cost reduction for electronic chemical manufacturing.
Novel nitrilase mutant enhances acetophenone acid production efficiency. Sustainable biocatalysis solution for reliable pharmaceutical intermediate supply chain optimization.
Discover a novel Ezetimibe synthesis method using titanium Lewis acids. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Patent CN103232400A discloses a solvent-free rare earth catalyzed route for quinazoline-2-thiones, offering high yields and simplified purification for pharmaceutical intermediates.
Patent CN101395140B reveals a high-yield process for 2-imidazolidinones using solid acid catalysts and hydrogenation, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN115947773A details a green, phosphorus-free synthesis for drospirenone intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN110452920A reveals high-efficiency enzymatic route for L-phenylglycine, offering supply chain stability and cost reduction for pharmaceutical intermediates manufacturing.
Analysis of patent CN1282746C reveals a microbial route for high-purity beta-amino alcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Advanced synthesis of alpha-isopropyl-3,4-dimethoxyphenylacetonitrile via patent CN113444020B. High-yield route for Verapamil intermediates with reduced toxicity and cost.
Patent CN104560905B reveals green enzymatic route for chiral sulfoxides. Enables cost reduction and sustainable supply chain for pharmaceutical intermediates manufacturing globally.